MATZNO Sumio

J-GLOBAL         Last updated: Sep 30, 2019 at 10:52
 
Avatar
Name
MATZNO Sumio
Affiliation
Kindai University
Section
Faculty of Pharmacy, Department of Pharmacy
Job title
Professor
Degree
Ph.D.(Osaka University), M.S.(Osaka University)

Research Interests

 
 

Research Areas

 
 

Academic & Professional Experience

 
Apr 2004
 - 
Mar 2010
Associate Professor, School of Pharmaceutical Sciences, Mukogawa Women's University
 
Mar 2003
 - 
Mar 2004
Visiting Scholar, Feinberg School of Medicine, Northwestern University
 
Apr 1990
 - 
Aug 1997
Research Division, The Green Cross Corporation
 
Sep 1997
 - 
Mar 2004
Assistant Professor, School of Pharmaceutical Sciences, Mukogawa Women's University
 
Apr 2010
 - 
Today
Professor, Faculty of Pharmacy, Kindai University
 

Education

 
 
 - 
1990
Graduate School, Division of Pharmaceutical Sciences, Osaka University
 
 
 - 
1988
Faculty of Pharmaceutical Science, Osaka University
 

Published Papers

 
An analysis of generic drug safety in paclitaxel and carboplatin chemotherapy for gynecologic malignancies
Fujimoto S, Yanae M, Asano H, Takeda T, Tsubaki M, Fujiwara K, Tsukioka Y, Matzno S, Morishima Y, Nishida S
12(2) 74-79   Dec 2018   [Refereed]
統合失調症患者における抗精神病薬の副作用発現因子に関する検討
松浦 正佳, 阪口 寛子, 高蓋 由美子, 竹中 凛代, 大鳥 徹, 松野 純男, 岩城 正宏, 北小路 学, 東 司
薬局薬学   10(1) 148-155   Apr 2018
統合失調症患者に、自己組織化マップを用いてクロルプロマジン(CP)換算値と関連性が高い検査項目の抽出を行い、CP換算値と各検査項目との関連性について重回帰分析を用いて検討した。その結果、入院期間、赤血球数、性別、A/G比、総ビリルビンの順でCP換算値との相関性が高いことが示された。さらに副作用発現の予測を行うため、統合失調症の病期を急性期と慢性期で分け、重回帰分析を用いて抗精神病薬の投与と血球系への影響を検討した結果、CP換算値の増加に伴い急性期では赤血球数、血小板数が増加する傾向にあるこ...
MATZNO Sumio, HACHIKEN Hiroko
2    2018   [Refereed]
A self-evaluation rubric system was introduced to statistical classes for university students in order to investigate the relationship between students’ satisfaction and their grades. Two items, “understanding” and “computer skill”, were reviewed ...
Otori T, Matzno S, Kawase A, Iwaki M, Kimachi T, Nishiwaki K, Figoni WC, Tominaga R, Asahide M, Nishikata M, Ishii Y, Matsuyama K
The Journal of pharmacy and pharmacology   68(12) 1527-1534   Dec 2016   [Refereed]
Kanda Y, Satoh R, Matsumoto S, Ikeda C, Inutsuka N, Hagihara K, Matzno S, Tsujimoto S, Kita A, Sugiura R
Journal of cell science   129(16) 3189-3202   Aug 2016   [Refereed]
薬剤師の禁煙支援に関する意識調査の多変量解析による問題点の抽出
高橋 直子, 松野 純男, 伊藤 栄次, 高橋 裕子
禁煙科学   10(2) P1-P12   Feb 2016
目的:タバコの煙には約4000種類の化学物質が含まれており、喫煙は多くの疾患の危険因子であるため、大きな課題である。薬剤師にとって禁煙支援は医療費削減および国民の健康維持をサポートする上で重要な業務となっている。そこで、薬剤師に喫煙や禁煙に関する意識調査を行って問題点を抽出し、禁煙支援に必要なものが何か検討した。方法:201X年および、201X+1年に某県薬剤師会禁煙支援薬剤師養成研修会に参加した薬剤師を対象に、『コーチングを活用した禁煙支援プログラム』の講義後、禁煙支援に関する意識調査を...
中心静脈栄養法(TPN)施行時に脂肪乳剤が血清アルブミン値へ与える影響
森住 誠, 坂本 千代子, 石原 美加, 松田 光弘, 松野 純男, 北小路 学
日本病院薬剤師会雑誌   51(6) 747-750   Jun 2015
静脈栄養時における脂肪乳剤の併用は、糖質の投与量や、総水分量を抑えた高エネルギー投与が可能となる。このようなメリットがあるにもかかわらず、我が国での脂肪乳剤併用率は低いのが実状である。そこで我々は、4週間以上の中心静脈栄養法(TPN)施行患者を対象に、脂肪乳剤の血清アルブミン(albumin:以下、Alb)値に影響を与える因子を重回帰分析にて探索した。その結果、Alb値に影響を与える因子として、非蛋白熱量(non-protein calorie:以下、NPC)における脂肪含有率、開始時Al...
Nagai Noriaki, Kim Yusei, Matzno Sumio, Matsuyama Kenji, Otori Toru
Jpn.J.Drug Inform.   16(3) 137-142   Nov 2014
The creation of the National Health Insurance program has greatly contributed to giving Japan the world's highest level of life expectancy.  However, the cost of medical care in Japan has increased as a result of an aging society.  In response to ...
Hagihara K, Mizukura A, Kitai Y, Yao M, Ishida K, Kita A, Kunoh T, Masuko T, Matzno S, Chiba K, Sugiura R
Genes to cells : devoted to molecular & cellular mechanisms   19(4) 325-337   Apr 2014   [Refereed]
堀部 明美, 松山 賢治, 松野 純男
薬局薬学   6(1) 37-42   2014
Matzno S, Ikeda C, Watanabe K, Nakamura R, Takamatsu H, Haginaka J, Matsuyama K
Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan   134(5) 655-663   2014   [Refereed]
大鳥徹, 長井紀章, 橋本佳幸, 金裕生, 松野純男, 松山賢治
医薬品情報学   15(3) 124-132   Nov 2013
草薙みか, 岩政かおり, 門間智恵, 山本倫数, 西山和香子, 高田充隆, 松野純男, 大里恭章
日本病院薬剤師会雑誌   49(11) 1181-1186   Nov 2013
Nakayama M, Fujiwara M, Nakamura T, Azuma T, Matzno S, Kamikonya N, Kimura T, Matsuyama K, Kawabata A
Jpn. J. Drug Inform.   15(3) 133-138   Nov 2013   [Refereed]
ASANO HAJIME, WATANABE MIZUKI, KAWAGUCHI AKINORI, YANAE MASASHI, FUNAKAMI YOSHINORI, WADA TETSUYUKI, MATSUNO SUMIO, YAMAZOE YUZURU, NISHIDA SHOZO, ICHIDA SEIJI
癌と化学療法   40(8) 1031-1036   Aug 2013   [Refereed]
Hagihara K, Kita A, Mizukura A, Yao M, Kitai Y, Kunoh T, Masuko T, Matzno S, Chiba K, Sugiura R
PloS one   8(12) e81907   2013   [Refereed]
Evaluation of injectable generic drugs using thermogravimetry and the influence of d-mannitol on the stability of gabexate mesilate
Otori T, Matzno S, Hyodo M, Sugimoto S, Kimura T, Matsuyama K
Intl. J. Pharm.Tech.   4(2) 4549-4559   Feb 2012   [Refereed]
Evaluation of higher clearance of serum vancomycin (VCM) after treatment of dilated cardiopathy with left ventricular assist system (LVAS) together with carperitide
Horibe A, Matzno S, Matsuyama K, Kurosawa N, Nakamura I, Yamashita D, Wada K, Okada H, Kohara N, Nakatani T
Jpn J.TDM   28(1) 7-13   Jan 2011
Akiyoshi T, Matzno S, Sakai M, Okamura N, Matsuyama K
Cancer chemotherapy and pharmacology   65(1) 143-150   Dec 2009   [Refereed]
Matzno S, Nishiguchi T, Akiyoshi T, Anami S, Nakabayashi T, Matsuyama K
The Journal of pharmacy and pharmacology   61(6) 781-788   Jun 2009   [Refereed]
Methods of preventing vinorelbine-induced phlebitis: an experimental study in rabbits.
Kohno E, Murase S, Nishikata M, Okamura N, Matzno S, Kuwahara T, Matsuyama K
International journal of medical sciences   5(4) 218-223   Jul 2008   [Refereed]
Matzno S, Yamaguchi Y, Akiyoshi T, Nakabayashi T, Matsuyama K
Biological & pharmaceutical bulletin   31(6) 1270-1273   Jun 2008   [Refereed]
Tomiyama N, Matzno S, Kitada C, Nishiguchi E, Okamura N, Matsuyama K
Biological & pharmaceutical bulletin   31(3) 369-374   Mar 2008   [Refereed]
Akiyoshi T, Tanaka N, Nakamura T, Matzno S, Shinozuka K, Uchida T
The Journal of pharmacy and pharmacology   59(11) 1521-1526   Nov 2007   [Refereed]
Tomiyama N, Yasuda N, Iwano C, Matzno S, Matsuyama K
Clinical and experimental pharmacology & physiology   34(9) 876-880   Sep 2007   [Refereed]
Sehgal BU, DeBiase PJ, Matzno S, Chew TL, Claiborne JN, Hopkinson SB, Russell A, Marinkovich MP, Jones JC
The Journal of biological chemistry   281(46) 35487-35498   Nov 2006   [Refereed]
Yoshida M, Matzno S, Namba H, Nishikata M, Matsuyama K
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy   12(3) 114-118   Jun 2006   [Refereed]
Matzno S, Yasuda S, Kitada Y, Akiyoshi T, Tanaka N, Juman S, Shinozuka K, Nakabayashi T, Matsuyama K
Life sciences   78(16) 1892-1899   Mar 2006   [Refereed]
Matzno S, Yasuda S, Juman S, Yamamoto Y, Nagareya-Ishida N, Tazuya-Murayama K, Nakabayashi T, Matsuyama K
The Journal of pharmacy and pharmacology   57(11) 1475-1484   Nov 2005   [Refereed]
Yasuda N, Matzno S, Iwano C, Nishikata M, Matsuyama K
Journal of pharmaceutical and biomedical analysis   39(3-4) 712-717   Sep 2005   [Refereed]
Tazuya-Murayama Keiko, Matzno Sumio, Yamada Kazuko, Nakabayashi Toshikatu, Uchida Takahiro, Matsuyama Kenji, Mishima Motohiro
Japanese journal of food chemistry   10(2) 78-84   Aug 2003
HMG-CoA (3-hydroxy-3-methylglutaryl-coenzyme A) reductase (EC 1.1.1.34) inhibitors (statins) are used for hypercholestemia. HMG-CoA reductase is the rate-limiting enzyme of cholesterol biosynthesis. Rhabdomyolysis is one of the most serious side e...
Matzno S, Tazuya-Murayama K, Tanaka H, Yasuda S, Mishima M, Uchida T, Nakabayashi T, Matsuyama K
The Journal of pharmacy and pharmacology   55(6) 795-802   Jun 2003   [Refereed]
Nakamura T, Akiyoshi T, Tanaka N, Shinozuka K, Matzno S, Nakabayashi T, Matsuyama K, Kashiwayanagi M, Uchida T
Biol. Pharm. Bull.   26(11) 1637-1640   2003
Clinical and Experimental Pharmacology and Physiology   25(5) 347-354   1998
OInhibition of Cholesterol Biosynthesis by Squalene Epoxidase Inhibitor Avoids Apoptotic Cell Death in L6 Myoblasts(共著)
Journal of Lipid Research   38(8) 1639-1648   1997
Possible Mechanism of Action of AE0047, a Calcium Antagonist, on Triglyceride Metabolism(共著)
Journal of Pharmacology and Experimental Therapeutics   282(2) 882-890   1997
Masahiro EDA, Tadahiro TAKEMOTO, Takehiro OKADA, Hiroshi SAKASHITA, Sumio MATZNO, Maki GOHDA, Kazutaka HAYASHI, Norifumi NAKAMURA, Chikara FUKAYA
Chemical and Pharmacological Bulletin   44(2) 307-313   1996
OA Possible Mechanism of Action of a New Potassium Channel Opener, AL0671, on Lipid Metabolism in Obese Zucker Rats(共著)
Journal of Pharmacology and Experimental Therapeutics   271(3) 1666-1671   1994
Ocollection of Acrosome-Reacted Human Sperm Using Monoclonal Antibody-Coated Paramagnetic Beads (共著)
Molecular Reproduction and Development   32(4) 389-393   1992
A Human Sperm Antigen Possibly Involved in Binding and/or Fusion with Zona-Free Hamster Eggs (共著)
Fertility and Sterility   54(6) 1121-1126   1990
Flow Cytometric Analysis of Mouse Sperm Using Monoclonal Anti-Sperm Antibody OBF13 (共著)
Journal of Reproductive Immunology   16(1) 71-82   1989
Effect of a Monoclonal Anti-Mouse Sperm Antibody (OBF13)on the Interaction of Mouse Sperm with Zona-Free Mouse and Hamster Eggs (共著)
Journal of Reproductive Immunology   13(3) 211-219   1988
Changing Role of Pharmacist in Revision of Medical Fee
Atsushi Murase, Manabu Kitakoji, Toru Otori, Sumio Matzno
J Community Pharm Pharm Sci   11(1) in press   Oct 2019   [Refereed]
In order to examine the role of the pharmacist in medical care, we analyzed “arrangement of the previous discussions related to the revision of medical service fees for 2014, 2016 and 2018”. Co-occurrence network analysis suggested that “hospital”...

Conference Activities & Talks

 
高橋直子, 高橋直子, 高橋直子, 松野純男, 伊藤栄次
日本薬学会年会要旨集(CD-ROM)   2019   
高橋直子, 高橋直子, 高橋直子, 松野純男, 伊藤栄次
日本プライマリ・ケア連合学会学術大会抄録集   2019   
高橋直子, 高橋直子, 高橋直子, 岸田洋平, 岸田洋平, 野村順二, 笹山周平, 保坂恵里奈, 安東貞喜, 安東貞喜, 竹内あずさ, 竹内あずさ, 松野純男, 伊藤栄次
日本プライマリ・ケア連合学会学術大会抄録集   2019   
松井大樹, 松野純男, 小野田良, 大星直樹
電子情報通信学会技術研究報告   8 Dec 2018   
中尾元紀, 松尾世為子, 大橋香菜子, 田邨保之, 永井聡子, 覺野律, 中村明美, 福永聖子, 川端成佐, 寺倉智子, 松野純男, 緒方文彦, 川崎直人, 大竹裕子, 長井紀章
国立病院総合医学会(Web)   2018   

Research Grants & Projects

 
Ministry of Education, Culture, Sports, Science and Technology: Grants-in-Aid for Scientific Research(基盤研究(C))
Project Year: 2010 - 2012    Investigator(s): Sumio MATZNO
In this study, the authors evaluated the effect of atypical antipsychotic agents (SGAs) on metabolic syndrome induction. Using neuroblastoma cell lines, one of SGAs, olanzapine, induced 5HT_<2C> mRNA transcription in PC12 autonomic neuroblastoma. ...
Ministry of Education, Culture, Sports, Science and Technology: Grants-in-Aid for Scientific Research(基盤研究(C))
Project Year: 2006 - 2007    Investigator(s): Kenji MATSUYAMA
The possibility of vitamin K3 (VK3) as an anticancer agent was assessed. VK3 dose-dependently diminished the cell viability (measured as esterase activity) with 1050 of 13. 7mM and Hill coefficient of 3. 1 in Hep G2 cells. It also decreased the po...
Study of the regulation process on skeletal muscle differentiation
Study of the mechanism of myopathy by drugs